Home
/ Forbius
/ Competitors

Forbius competitors and similar companiesClear all

Forbius's competitors and similar companies include Agios Pharmaceuticals, CytomX Therapeutics, Rakuten Medical and Bolt Biotherapeutics.

	Forbius Forbius (also known as Formation Biologics) is a protein engineering company that develops biotherapeutics for the treatment of cancer and fibrotic diseases.	Agios Pharmaceuticals Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism.	CytomX Therapeutics CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.	Rakuten Medical Rakuten Medical (formerly Rakuten Aspyrian) is a clinical stage biotechnology company developing tumor-targeted precision therapies.	Bolt Biotherapeutics Bolt Biotherapeutics is a biotechnology company developing immunotherapeutics for multiple types of cancer.
Founding Date	Founding Date 2011	Founding Date 2008	Founding Date 2008	Founding Date 2013	Founding Date 2015
Type	Type Subsidiary	Type Public	Type Public	Type Private	Type Public
Tags	Tags Healthcare bioengineering biotech drug development oncology pharma	Tags Healthcare drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma therapy	Tags Technology biotech oncology platform therapy
Locations	Locations Austin, US HQ Montréal, CA	Locations Cambridge, US HQ	Locations South San Francisco, US HQ	Locations San Diego, US HQ Setagaya City, JP Amsterdam, NL Ecublens, CH Taipei, TW Taipei, TW San Mateo, US	Locations Redwood City, US HQ
Employees	Employees 109% decrease	Employees 53611% increase	Employees 15815% increase	Employees 1516% decrease	Employees 63
Valuation ($)	Valuation ($) N/A	Valuation ($) 1.3 b	Valuation ($) 139.4 m	Valuation ($) N/A	Valuation ($) 55.4 m
Twitter followers	Twitter followers 97	Twitter followers 2.5 k	Twitter followers 1.1 k	Twitter followers N/A	Twitter followers 313
Number of tweets (last 30 days)	Number of tweets (last 30 days) N/A	Number of tweets (last 30 days) 19	Number of tweets (last 30 days) N/A	Number of tweets (last 30 days) N/A	Number of tweets (last 30 days) 6
Average likes per tweet (last 30 days)	Average likes per tweet (last 30 days) N/A	Average likes per tweet (last 30 days) 7.9	Average likes per tweet (last 30 days) N/A	Average likes per tweet (last 30 days) N/A	Average likes per tweet (last 30 days) 4.5
Percentage of tweets with engagement (last 30 days)	Percentage of tweets with engagement (last 30 days) N/A	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) N/A	Percentage of tweets with engagement (last 30 days) N/A	Percentage of tweets with engagement (last 30 days) 100%
Employee Rating	Employee Rating 2.8	Employee Rating 4.1	Employee Rating 3.7	Employee Rating 2.1	Employee Rating 5
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $14.2m (FY, 2022)	Revenue (est.) $69.6m (FY, 2021)	Revenue (est.) N/A	Revenue (est.) $1.3m (FY, 2021)
Net income	Net income N/A	Net income ($231.8m) (FY, 2022)	Net income ($83.6m) (FY, 2021)	Net income N/A	Net income ($98.6m) (FY, 2021)
Operating ⚠
Patents (US)	Patents (US) N/A	Patents (US) N/A	Patents (US) 13 (FY, 2016)	Patents (US) N/A	Patents (US) 1 (FY, 2020)
Funding
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 132.4m	Total funding raised $ 451.9m	Total funding raised $ 177.5m